LabMinds is an award-winning lab automation robotics company focused on automating solution preparation with its Revo technology. The company's core product is the Revo automated solution preparation system, which automates manual buffer solution preparation used across drug-development labs. LabMinds plans to commercialize the Revo system, develop new products, and expand its team. Company leadership and investors say customer feedback and validation for Revo have been positive and that the technology addresses time- and resource-wasting manual processes. The company completed an oversubscribed $6.4M funding round in the third quarter to support these initiatives. LabMinds' management emphasized that automating buffer preparation will free scientists to focus on drug development.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2021